100 related articles for article (PubMed ID: 10721445)
1. [The best of arrhythmias in 1999].
Aliot E
Arch Mal Coeur Vaiss; 2000 Jan; 93(1 Spec No):25-31. PubMed ID: 10721445
[TBL] [Abstract][Full Text] [Related]
2. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
Siddiqui A; Kowey PR
Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic therapy in heart failure.
Eckardt L; Haverkamp W; Breithardt G
Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
[TBL] [Abstract][Full Text] [Related]
4. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
[TBL] [Abstract][Full Text] [Related]
5. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
Ohnishi S; Kasanuki H
J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
[TBL] [Abstract][Full Text] [Related]
6. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
7. Prevention of sudden cardiac death.
Goldberger JJ
Heart Dis; 2000; 2(4):305-13. PubMed ID: 11728274
[TBL] [Abstract][Full Text] [Related]
8. [Arterial hypertension and cardiac arrhythmias].
Vester EG
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
[TBL] [Abstract][Full Text] [Related]
9. [Cardiac insufficiency: prevention of ventricular arrhythmias].
Mabo P; Leclercq C; Pavin D
Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():23-8. PubMed ID: 10830085
[TBL] [Abstract][Full Text] [Related]
10. The role of beta-adrenergic blocking agents in preventing sudden cardiac death.
Pitt B
Circulation; 1992 Jan; 85(1 Suppl):I107-11. PubMed ID: 1345815
[TBL] [Abstract][Full Text] [Related]
11. The role of beta-blockers in preventing sudden death in heart failure.
Teerlink JR; Massie BM
J Card Fail; 2000 Jun; 6(2 Suppl 1):25-33. PubMed ID: 10908095
[TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
13. [The patient at risk of sudden death:value of drug therapy].
Bonhorst D
Rev Port Cardiol; 2000 Feb; 19(2):233-9. PubMed ID: 10763353
[TBL] [Abstract][Full Text] [Related]
14. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
Alboni P
Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
[TBL] [Abstract][Full Text] [Related]
15. Cardiac arrhythmias.
Hammill SC
J Am Coll Cardiol; 2004 Jul; 44(2 Suppl A):16A-18A. PubMed ID: 15261685
[No Abstract] [Full Text] [Related]
16. [Chronic heart failure and sudden death: the message of CIBIS-III].
Dequarti MC; Poggio L; Vanoli E
Recenti Prog Med; 2007 Dec; 98(12):638-45. PubMed ID: 18369041
[TBL] [Abstract][Full Text] [Related]
17. [Defibrillators--end of sudden cardiac death?].
Kozák M
Vnitr Lek; 2004 Oct; 50 Suppl 1():S63-7. PubMed ID: 15651143
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockers for preventing sudden cardiac death.
Giles TD; Basile JN
Postgrad Med; 2003 Dec; 114(6 Suppl Role):30-4. PubMed ID: 19667667
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
[TBL] [Abstract][Full Text] [Related]
20. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
